Who invested in ILiAD Biotechnologies?
ILiAD Biotechnologies's investors include RA Capital Management, BNP Paribas, Janus Henderson Investors and National Institute of Allergy and Infectious Diseases.

United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$116Mraised across 2 rounds since 2015, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $116M sold, first sale Feb 2026
No investor was named in the report.
From a historical funding recordSEC filing: $640K sold, first sale Oct 2015
From ILiAD Biotechnologies's own website: 3 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
ILiAD Biotechnologies's investors include RA Capital Management, BNP Paribas, Janus Henderson Investors and National Institute of Allergy and Infectious Diseases.
ILiAD Biotechnologies has raised $116M across 2 rounds since 2015.
ILiAD Biotechnologies's most recent round was a Series D of $115M in Feb 2026.
Its most recent round, $115M in Feb 2026, is also its largest on record.
ILiAD Biotechnologies's first round on record, in Feb 2026, was backed by RA Capital Management, BNP Paribas and Janus Henderson Investors and 1 others.
ILiAD Biotechnologies's latest named round is a Series D, in Feb 2026.
ILiAD Biotechnologies is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.